PMV Pharmaceuticals, Inc. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: pure
Description
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary
PMV Pharmaceuticals, Inc. quarterly/annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from Q2 2023 to Q3 2024.
  • PMV Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending September 30, 2024 was 0 pure.
  • PMV Pharmaceuticals, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
  • PMV Pharmaceuticals, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21 pure, unchanged from 2021.
  • PMV Pharmaceuticals, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2021 was 0.21 pure, unchanged from 2020.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 0 0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 0.93 +0.93 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q3 2023 0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.